2016 ACBS Landline-Cellphone Combined Prevalence Tables

BRFSS Asthma Call-back Survey Prevalence TABLE 8b. Estimated percent advised to make environmental changes for active1 and inactive2 asthma status among adults3 ever diagnosed with asthma by state/territory – BRFSS Asthma Call-back Survey, United States, 2016.

Table 8B LLCP
State/Territory Active Inactive
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Arizona 357 35.1 4.6 (26.1 – 44.1) 98 N/A N/A (N/A – N/A)
California 263 35.8 3.9 (28.2 – 43.4) 104 27.9 7.1 (14.0 – 41.8)
Connecticut 316 37.2 4.1 (29.2 – 45.2) 92 18.0 4.9 (8.4 – 27.6)
Florida 978 27.8 3.2 (21.5 – 34.1) 279 21.5 5.0 (11.7 – 31.3)
Georgia 157 35.6 5.5 (24.8 – 46.4) 58 N/A N/A (N/A – N/A)
Hawaii 246 30.9 4.8 (21.5 – 40.3) 112 16.6 4.5 (7.8 – 25.4)
Illinois 176 35.6 5.2 (25.4 – 45.8) 57 N/A N/A (N/A – N/A)
Indiana 468 41.9 3.6 (34.8 – 49.0) 86 32.7 7.5 (18.0 – 47.4)
Iowa 189 33.5 5.1 (23.5 – 43.5) 59 N/A N/A (N/A – N/A)
Kansas 387 37.6 3.6 (30.5 – 44.7) 114 31.5 5.9 (19.9 – 43.1)
Maine 577 43.5 3.4 (36.8 – 50.2) 152 28.2 5.9 (16.6 – 39.8)
Massachusetts 218 36.1 4.5 (27.3 – 44.9) 49 N/A N/A (N/A – N/A)
Michigan 661 38.7 2.6 (33.6 – 43.8) 176 25.0 4.1 (17.0 – 33.0)
Minnesota 604 29.3 2.3 (24.8 – 33.8) 155 23.0 3.9 (15.4 – 30.6)
Missouri 278 34.5 5.5 (23.7 – 45.3) 56 N/A N/A (N/A – N/A)
Montana 194 32.2 5.5 (21.4 – 43.0) 64 N/A N/A (N/A – N/A)
Nebraska 472 24.2 3.5 (17.3 – 31.1) 147 36.4 7.3 (22.1 – 50.7)
Nevada 158 34.5 5.9 (22.9 – 46.1) 47 N/A N/A (N/A – N/A)
New Hampshire 218 44.0 5.1 (34.0 – 54.0) 62 38.4 9.1 (20.6 – 56.2)
New Jersey 293 24.6 3.8 (17.2 – 32.0) 68 37.5 9.9 (18.1 – 56.9)
New Mexico 209 32.7 5.2 (22.5 – 42.9) 59 N/A N/A (N/A – N/A)
New York 461 31.0 4.0 (23.2 – 38.8) 124 33.4 9.4 (15.0 – 51.8)
Ohio 451 33.1 3.8 (25.7 – 40.5) 122 16.9 4.8 (7.5 – 26.3)
Oklahoma 153 31.1 5.5 (20.3 – 41.9) 44 N/A N/A (N/A – N/A)
Oregon 165 42.5 4.4 (33.9 – 51.1) 64 16.7 4.8 (7.3 – 26.1)
Pennsylvania 262 30.3 4.0 (22.5 – 38.1) 77 17.7 5.1 (7.7 – 27.7)
Rhode Island 189 30.8 5.4 (20.2 – 41.4) 46 34.3 10.0 (14.7 – 53.9)
Texas 375 31.2 4.7 (22.0 – 40.4) 120 N/A N/A (N/A – N/A)
Utah 335 26.9 3.4 (20.2 – 33.6) 128 18.4 5.2 (8.2 – 28.6)
Vermont 245 44.6 4.7 (35.4 – 53.8) 77 25.7 6.5 (13.0 – 38.4)
Wisconsin 220 35.6 4.7 (26.4 – 44.8) 60 N/A N/A (N/A – N/A)
Puerto Rico 323 44.3 4.3 (35.9 – 52.7) 95 34.8 6.9 (21.3 – 48.3)
32 states / area 10,598 33.8 1.0 (31.8 – 35.8) 3,051 24.8 2.0 (20.9 – 28.7)
Median 34.5 26.8
Range 24.2-44.6 16.6-38.4

 
 

1 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

2 Reported none of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

3 Aged ≥ 18 years

± Landline and cell phone combined sample size excludes “DK/Refused”

§ Standard error

Confidence interval

N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30

Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2016/pdf/sdq_report_acbs_16-508.pdfpdf icon